Infections Influenza

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Influenza Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Influenza Projects
--Bharat Biotech International Limited
--Baxter International Inc
--BioDiem Ltd
--BioCryst Pharmaceuticals Inc
--CSL Limited
--Crucell N V
--Iomai Corp
--GlaxoSmithKline plc
--Novavax Inc
--Novartis AG
--Sanofi-Aventis
--Protein Sciences Corporation

--Top Companies in early stage Influenza Projects
--Altea Therapeutics
--AlphaVax, Inc.
--AVI BioPharma Inc
--AstraZeneca Plc
--Baxter International Inc
--Avir Green Hills Biotechnology AG
--Biota Holdings Limited
--BioCryst Pharmaceuticals Inc
--Crucell N V
--Carrington Laboratories Inc
--Iomai Corp
--Erimos Pharmaceuticals
--NexBio Incorporated
--NanoViricides, Inc.
--Solvay S.A.
--Onepharm
--Variation Biotechnologies Inc.
--The Quigley Corporation
--VaxInnate Corp.
--Vaxart, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View